Government relations service provider Public Policy Holding Company (PPHC.US) applies for IPO in the US, aiming to raise $60 million.
The Public Policy Holding Company, which provides government relations and communication services to businesses and non-profit organizations, has submitted an application to the SEC to raise up to $60 million through an IPO.
Public Policy Holding Company (PPHC), which provides government relations and communication services to businesses and non-profit organizations, submitted an application to the U.S. Securities and Exchange Commission (SEC) last Friday to raise up to $60 million through an initial public offering (IPO).
PPHC is a global communication and public affairs consulting group that offers government relations, corporate communication, and compliance services through its business network of 12 member companies. Currently, the company serves approximately 1,300 active clients worldwide in industries such as healthcare, finance, energy, technology, and transportation. PPHC has offices in the United States, the United Kingdom, Shanghai, Abu Dhabi, and Dubai to assist clients in managing regulatory risks, addressing public policy challenges, and maintaining corporate reputation in multiple jurisdictions.
It is worth mentioning that PPHC is currently listed on the London Stock Exchange's AIM market under the stock symbol "PPHC."
Founded in Washington D.C. in 2014, the company generated revenue of $166 million in the 12-month period ending on June 30, 2025. For the upcoming IPO on the Nasdaq Stock Exchange, PPHC plans to retain the stock symbol "PPHC." The company reportedly submitted a confidential listing application on September 4, 2025, with Oppenheimer & Co., Canaccord Genuity, and Texas Capital Securities serving as joint book-runners for the transaction. However, the specific pricing terms have not been disclosed by the company as of now.
Related Articles

Smart flying golden Thai(688443.SH): Celltrion's monoclonal antibody injection included in the 2025 National Medical Insurance Catalog.

HaiChuang Pharmaceuticals (688302.SH)Daon Zalu Amin soft capsules have been included in the 2025 National Medical Insurance Drug List.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH)Innovative drugs Avimeplanib and Golirelin included in the new version of the national medical insurance directory.
Smart flying golden Thai(688443.SH): Celltrion's monoclonal antibody injection included in the 2025 National Medical Insurance Catalog.

HaiChuang Pharmaceuticals (688302.SH)Daon Zalu Amin soft capsules have been included in the 2025 National Medical Insurance Drug List.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH)Innovative drugs Avimeplanib and Golirelin included in the new version of the national medical insurance directory.






